Roger William Gunnarsson
Direktor/Vorstandsmitglied bei Axcentua Pharmaceuticals AB
Profil
Roger William Gunnarsson is the founder of Orphan Europe SARL, which was founded in 1990.
He held the position of Chief Executive Officer from 2007 to 2008.
Currently, he is a Director at Synphora AB, Axcentua Pharmaceuticals AB, Premacure AB, Laccure AB, Cormorant Pharmaceuticals AB, Laccure Development AB, Premalux AB, Sixera Pharma AB, and Gesynta Pharma AB.
He previously held the position of Independent Non-Executive Director at Recordati SpA from 2008 to 2011.
He also held director positions at ProstaLund Operations AB, Adenovir Pharma AB, Sensidose AB, and ProstaLund AB.
He was a Manager-Sales at Bristol Myers Co. and a Principal at Nobel Pharma Chemistry.
He was also the President of Nobel Pharma, Inc. Dr. Gunnarsson received his undergraduate degree from the University of Gothenburg in 1973 and his undergraduate degree from the Royal Swedish Marine Academy in 1967.
Aktive Positionen von Roger William Gunnarsson
| Unternehmen | Position | Beginn |
|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | 19.04.2010 |
Premacure AB
 Premacure AB Pharmaceuticals: MajorHealth Technology Premacure AB owns shares and acquires securities, patents, rights and licenses from other businesses. It is also involved in biotechnology and medicine. The company is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | 18.05.2011 |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Direktor/Vorstandsmitglied | 18.05.2011 |
Synphora AB
 Synphora AB Pharmaceuticals: MajorHealth Technology The Swedish company was founded in 2004 by Johan Stjernschantz and is currently led by CEO Fredrik Henell. | Direktor/Vorstandsmitglied | - |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Direktor/Vorstandsmitglied | - |
| Laccure Development AB | Direktor/Vorstandsmitglied | - |
| Premalux AB | Direktor/Vorstandsmitglied | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Direktor/Vorstandsmitglied | - |
Sixera Pharma AB
 Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Roger William Gunnarsson
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Roger William Gunnarsson
| University of Gothenburg | Undergraduate Degree |
| Royal Swedish Marine Academy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| RECORDATI | Health Technology |
| PROSTALUND AB | Health Technology |
| SENSIDOSE AB | Electronic Technology |
| Private Unternehmen | 15 |
|---|---|
| Bristol Myers Co. | Health Technology |
ProstaLund Operations AB
 ProstaLund Operations AB Electronic Equipment/InstrumentsElectronic Technology ProstaLund Operations AB develops and manufactures medical equipment. It specializes on devices and treatments of urological conditions primarily for Benign Prostatic Hyperplasia (BPH). The company was incorporated in 1989 and is headquartered in Uppsala, Sweden. | Electronic Technology |
Nobel Pharma Chemistry
 Nobel Pharma Chemistry Pharmaceuticals: OtherHealth Technology Part of Cambrex Corp., Nobel Pharma Chemistry is a Swedish company that specializes in producing bulk chemicals used in drugs. Nobel Pharma Chemistry was acquired by Cambrex Corp. from Akzo Nobel NV on October 13, 1994 for $130 million. | Health Technology |
Synphora AB
Synphora AB Pharmaceuticals: MajorHealth Technology The Swedish company was founded in 2004 by Johan Stjernschantz and is currently led by CEO Fredrik Henell. | Health Technology |
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
Premacure AB
Premacure AB Pharmaceuticals: MajorHealth Technology Premacure AB owns shares and acquires securities, patents, rights and licenses from other businesses. It is also involved in biotechnology and medicine. The company is headquartered in Stockholm, Sweden. | Health Technology |
Laccure AB
Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |
Cormorant Pharmaceuticals AB
Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Health Technology |
| Laccure Development AB | |
| Premalux AB | |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Health Technology |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Health Technology |
Orphan Europe SARL
 Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Health Technology |
Adenovir Pharma AB
 Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |
Nobel Pharma, Inc.
 Nobel Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Nobel Pharma, Inc. is a Japanese company that engages in the research and development of drugs. The private company is based in Tokyo, Japan. | Commercial Services |
